Erratum to: Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry [Breast Cancer Research and Treatment, 149, 1, (2015) 223-227, DOI 10.1007/s10549-014-3218-x];Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry

Breast Cancer Research and Treatment

Volumn 149, Issue 1, 2015, Pages 223-227

  Rosenthal, Eric ^a   Moyes, Kelsey ^a   Arnell, Christopher ^a   Evans, Brent ^a   Wenstrup, Richard J ^a  

^a Utah   (United States)

Author keywords

Ashkenazi Jewish; BRCA1; BRCA2; Founder mutations; Hereditary Breast and Ovarian Cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; ASHKENAZI JEWISH ANCESTRY; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; HUMAN; JEW; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION; GENETICS; MUTATION; OVARIAN NEOPLASMS; PATHOLOGY; RISK FACTOR;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; JEWS; MUTATION; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 84925543786     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3361-z     Document Type: Erratum

References (13)

1. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694–1706. doi:10.1093/jnci/djj465
2. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83(10):1301–1308. doi:10.1054/bjoc.2000.1407
3. Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF (2000) Risk models for familial ovarian and breast cancer. Genet Epidemiol 18(2):173–190. doi:10.1002/(SICI)1098-2272(200002)18:2<173:AID-GEPI6>3.0.CO;2-R
4. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14(2):185–187. doi:10.1038/ng1096-185
5. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64(4):963–970
6. King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646. doi:10.1126/science.1088759
7. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA (2000) BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66(4):1259–1272. doi:10.1086/302853
8. National Comprehensive Cancer Network (2014) Genetic/familial high-risk assessment: breast and ovarian. NCCN Clinical Practice Guidelines in Oncology (1.2014)
9. Kauff ND, Perez-Segura P, Robson ME, Scheuer L, Siegel B, Schluger A, Rapaport B, Frank TS, Nafa K, Ellis NA, Parmigiani G, Offit K (2002) Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 39(8):611–614
10. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480–1490
11. Judkins T, Rosenthal E, Arnell C, Burbidge LA, Geary W, Barrus T, Schoenberger J, Trost J, Wenstrup RJ, Roa BB (2012) Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 118(21):5210–5216. doi:10.1002/cncr.27556
12. Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME (2010) Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Breast Cancer Res Treat 123(2):581–585. doi:10.1007/s10549-010-0818-y
13. Beaudet AL, Tsui LC (1993) A suggested nomenclature for designating mutations. Hum Mutat 2(4):245–248. doi:10.1002/humu.1380020402